Asset Management One Co., Ltd. Innoviva, Inc. Transaction History

Asset Management One Co., Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $1.29 Million - $1.47 Million	-98,522 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $24,313 - $35,626	-1,776 Reduced 1.77%	98,522 $1.38 Million
Q4 2018 Feb 13, 2019	BUY	$13.96 - $18.26 $1.4 Million - $1.83 Million	100,298 New	100,298 $1.7 Million

227

79M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.34B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asset Management One Co., Ltd. with notifications on news.